Cartalax .

Cartalax  is a highly purified synthetic cytomedin peptide developed for advanced scientific research involving cartilage biology, connective tissue physiology, and peptide-mediated molecular signaling. As a member of the Khavinson peptide family, Cartalax has attracted significant attention in peptide science for its well-defined structure and its utility in investigating tissue-specific cellular regulation and gene expression under controlled laboratory conditions.

Researchers employ Cartalax to study molecular pathways associated with cartilage homeostasis, extracellular matrix organization, chondrocyte biology, and intracellular communication. Experimental investigations continue to explore its interactions with transcriptional processes, protein synthesis, and peptide-regulated signaling networks to advance scientific understanding of connective tissue biology and cellular regulation. These studies contribute valuable insights into peptide pharmacology, molecular biology, and regenerative research.

The precisely characterized composition of Cartalax (20mg) makes it an excellent research tool for academic institutions, biotechnology companies, and pharmaceutical laboratories conducting advanced peptide investigations. Its consistent biochemical profile supports reproducible studies involving peptide-receptor interactions, molecular signaling cascades, and tissue-specific biological mechanisms.

Manufacturers produce Cartalax (20mg) as a high-purity, research-grade lyophilized peptide using stringent manufacturing standards and comprehensive analytical quality control. Every production batch undergoes rigorous testing to verify identity, purity, potency, and batch-to-batch consistency, ensuring researchers receive a dependable peptide suitable for demanding laboratory applications.

Product Information

• Product Name: Cartalax
• Strength: 20mg per vial
• Peptide Class: Synthetic cytomedin peptide
• Appearance: White to off-white lyophilized powder
• Grade: Research grade
• Purity: High purity (Certificate of Analysis available for applicable batches)
• Intended Use: Laboratory research only

Research Applications

Researchers commonly utilize Cartalax (20mg) in studies involving:

• Cartilage tissue biology
• Chondrocyte and connective tissue research
• Extracellular matrix regulation
• Cellular signaling pathways
• Gene expression and transcriptional regulation
• Molecular and cellular biology
• Biotechnology and pharmaceutical research
• Experimental peptide pharmacology

Quality Assurance

Every batch of Cartalax undergoes comprehensive analytical testing to verify identity, purity, potency, and consistency before release. Strict quality assurance protocols support dependable laboratory performance and reproducible scientific results across academic, biotechnology, and pharmaceutical research facilities.

Storage

Store the lyophilized peptide in a cool, dry laboratory environment protected from moisture, excessive heat, and direct light. After reconstitution, follow validated laboratory storage procedures to preserve peptide stability and maintain sample integrity.

Disclaimer

Cartalax (20mg) is supplied exclusively for scientific and laboratory research purposes. This product is not intended for human consumption, clinical use, veterinary applications, therapeutic treatment, or diagnostic procedures. Qualified laboratory professionals should handle this research peptide in accordance with established laboratory practices, institutional guidelines, and all applicable regulations.